Antipsychotic prescribing behavior dementia care homes systematic review a b s t r a c t Background: Antipsychotic medications are commonly used to manage the behavioral and psychological symptoms of dementia. Several large studies have demonstrated an association between treatment with antipsychotics and increased morbidity and mortality in people with dementia. Aims: To assess the effectiveness of interventions used to reduce inappropriate prescribing of antipsychotics to the elderly with dementia in residential care. Method: Systematic searches were conducted in 12 electronic databases. Reference lists of all included studies and forward citation searching using Web of Science were also conducted. All quantitative studies with a comparative research design and studies in which recognized methods of qualitative data collection were used were included. Articles were screened for inclusion independently by 2 reviewers. Data extraction and quality appraisal were performed by 1 reviewer and checked by a second with discrepancies resolved by discussion with a third if necessary. Results: Twenty-two quantitative studies (reported in 23 articles) were included evaluating the effectiveness of educational programs (n ¼ 11), in-reach services (n ¼ 2), medication review (n ¼ 4), and multicomponent interventions (n ¼ 5). No qualitative studies meeting our inclusion criteria were identified. Eleven studies were randomized or controlled in design; the remainder were uncontrolled before and after studies. Beneficial effects were seen in 9 of the 11 studies with the most robust study design with reductions in antipsychotic prescribing levels of between 12% and 20%. Little empirical information was provided on the sustainability of interventions. Conclusion: Interventions to reduce inappropriate prescribing of antipsychotic medications to people with dementia resident in care homes may be effective in the short term, but longer more robust studies are needed. For prescribing levels to be reduced in the long term, the culture and nature of care settings and the availability and feasibility of nondrug alternatives needs to be addressed. 
a b s t r a c t
Background: Antipsychotic medications are commonly used to manage the behavioral and psychological symptoms of dementia. Several large studies have demonstrated an association between treatment with antipsychotics and increased morbidity and mortality in people with dementia. Aims: To assess the effectiveness of interventions used to reduce inappropriate prescribing of antipsychotics to the elderly with dementia in residential care. Method: Systematic searches were conducted in 12 electronic databases. Reference lists of all included studies and forward citation searching using Web of Science were also conducted. All quantitative studies with a comparative research design and studies in which recognized methods of qualitative data collection were used were included. Articles were screened for inclusion independently by 2 reviewers. Data extraction and quality appraisal were performed by 1 reviewer and checked by a second with discrepancies resolved by discussion with a third if necessary.
Results: Twenty-two quantitative studies (reported in 23 articles) were included evaluating the effectiveness of educational programs (n ¼ 11), in-reach services (n ¼ 2), medication review (n ¼ 4), and multicomponent interventions (n ¼ 5). No qualitative studies meeting our inclusion criteria were identified. Eleven studies were randomized or controlled in design; the remainder were uncontrolled before and after studies. Beneficial effects were seen in 9 of the 11 studies with the most robust study design with reductions in antipsychotic prescribing levels of between 12% and 20%. Little empirical information was provided on the sustainability of interventions. Conclusion: Interventions to reduce inappropriate prescribing of antipsychotic medications to people with dementia resident in care homes may be effective in the short term, but longer more robust studies are needed. For prescribing levels to be reduced in the long term, the culture and nature of care settings and the availability and feasibility of nondrug alternatives needs to be addressed. Antipsychotic medications are often prescribed to manage the behavioral and psychological symptoms of dementia (BPSD). However, several large studies have demonstrated a clear association between treatment with antipsychotic drugs and increased morbidity and mortality in people with dementia.
1e3 Treatment guidelines recommend that the first-line management of BPSD should be detailed
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The authors declare no conflicts of interest. The most recent UK audit of primary care data showed a decrease in antipsychotic prescribing to individuals with dementia from approximately 17% in 2006 to 7% in 2011. 10 The audit showed widespread and significant variation in practice across the country, ranging from approximately 3% of individuals with dementia receiving antipsychotic medication at the time of the audit in London and the southeast to approximately 13% in the northwest. The audit provided no information on duration of prescription or on the residential setting of people with dementia and represents data from approximately 50% of general practices in the United Kingdom. Audit studies based in nursing homes have generally reported a higher prevalence of antipsychotic prescription among individuals with dementia. Anecdotally, we are aware of a variety of interventions being used to assess, evaluate, and review the prescription of antipsychotic medications in care homes. These include education and raising staff awareness, development and use of decision-making pathways, medication checklists, mood, pain and behavioral charts, advice on nondrug-based alternatives, regular medication review by pharmacists, community or hospital-based psychiatrists and general practitioners, interdisciplinary education programs, and pharmacist-led strategies.
The purpose of this systematic review was to assess the effectiveness of interventions used to reduce inappropriate prescribing of antipsychotic medications to individuals with dementia resident in care homes to help to inform the provision of services. We also were interested in published accounts of the views and experiences of prescribers of included interventions to highlight barriers and facilitators to the successful implementation of such interventions.
Methods
The systematic review was conducted following the general principles published by the NHS Centre for Reviews and Dissemination (CRD). 15 A predefined protocol was developed following consultation with topic and methods experts and is registered with PROSPERO (PROSPERO 2012:CRD42012003425).
Literature Search and Eligibility Criteria
A comprehensive search syntax using MeSH and free text terms was developed by an information specialist (M.R.) in consultation with the review team ( We were interested in the effectiveness of interventions (eg, staff training, regular medication review) designed to reduce inappropriate prescription of antipsychotic medications to individuals with dementia in community residential care settings. Interventions had to be aimed at professionals (eg, general practitioners, community psychiatrists, pharmacists) responsible for prescription of these medications in these settings. We also were interested in reports of the views and experiences of prescribers using the included interventions.
All quantitative studies reporting comparative data were included. Qualitative studies using recognized methods of qualitative data collection (eg, focus groups, interviews, and observation) and analysis (grounded theory, narrative analysis, thematic analysis, discourse analysis) were sought. 
Study Selection
The search results were uploaded to reference management software (Endnote X5, V5; Thomson Reuters, Philadelphia, PA). Titles and abstracts were screened for relevance independently by 2 reviewers (J.T.C., M.R., or R.A.), with any disagreements being resolved by discussion and involvement of a third reviewer (J.T.C., M.R., or R.A.) where necessary. The full text of potentially relevant articles was retrieved and screened in the same way using the prespecified inclusion and exclusion criteria. All duplicate articles were doublechecked and excluded.
Data Collection
For each study, details of the intervention, the characteristics of those receiving it, the characteristics of the patient population involved, the setting, the study methods, and outcomes relating to medication use were recorded. Data were extracted by one reviewer (J.T.C. or M.R.) into a data extraction form based on the Cochrane Effective Practice and Organisation of Care Review Group Data Collection Checklist, 16 which was piloted on several studies and refined. The
Cochrane Effective Practice and Organisation of Care Review Group Data Collection Checklist includes a taxonomy of intervention components, which was completed for each trial as part of this process. Data were collected from published articles only; manuals were not requested from trial authors. All data extraction was checked by a second reviewer (J.T.C. or M.R.) with discrepancies resolved by discussion and involvement of a third reviewer (R.A.) where necessary.
Risk of Bias
The quality of all included studies was appraised by one reviewer (J.T.C.) and checked by a second (M.R., R.A., or R.W.). In an amendment to the published protocol, all articles were appraised using the Effective Public Health Practice Project tool 17 to enable assessment of all study designs with the same rubric. Appraisal considered the method of sample selection, potential for bias connected with study design, differences between groups at baseline and how these were dealt with in the analysis, assessment of outcome measures, description of the flow of patients through the study, and use of a valid and reliable primary outcome measure.
Data Synthesis
Changes in medication use were reported in all included studies. However, the multitude of different formats in which the data were provided and the range of included study designs precluded formal pooling of the data. For example, among the randomized studies, medication use was variously reported as psychoactive drug use score, proportion of residents who had antipsychotic medications discontinued, number of days of antipsychotic therapy per patient per month, proportion of residents taking antipsychotic medications, and dose of antipsychotic medication. Data were therefore tabulated, grouped according to study design and outcome, and discussed narratively.
Results
The electronic searches retrieved a total of 5071 unique citations. Screening of title and abstracts against the inclusion and exclusion criteria resulted in the retrieval of the full text of 80 articles. Fiftynine articles were excluded because the following aspects of the article did not meet the inclusion criteria: population (n ¼ 3), intervention (n ¼ 14), reported outcomes (n ¼ 1), and study design (n ¼ 32). Six articles were published as conference abstracts only with insufficient information provided and we were unable to locate a full-text publication despite contact with authors, and 3 were duplicate publications. One additional article was located through hand searching of the bibliographies of identified systematic review articles. The update search identified an additional 985 articles, of which 7 were retrieved in full text and 1 article met the inclusion criteria. A total of 23 articles were included, describing 22 studies. Figure 1 shows the flow of studies through the review. Table 2 shows the study characteristics of all included articles. All the included studies provided quantitative data. We did not identify any articles reporting the views and experiences of prescribers with specific interventions. Our search identified a number of qualitative articles exploring factors that influence prescribing practice in care homes; these are considered further in the discussion.
Study Characteristics
Six of the studies are randomized, 14 ,18e22 5 have a controlled design, 23e28 and 11 are uncontrolled before and after studies. 29e39 The studies were published between 1987 and 2013 and were conducted in the United States (n ¼ 8), the United Kingdom (n ¼ 5), Canada (n ¼ 5), Australia (n ¼ 2), Norway, and Sweden. Very little demographic information was provided about the people (physicians, nurses, pharmacists, and so forth) who received the interventions and in most studies it is not clear how many prescribers were involved. The studies ranged in size from 21 to 7000; approximately 19,300 people with dementia were included in total (information not provided in all studies).
Intervention Characteristics
Descriptions of the interventions used in the studies are shown in Table 3 . We grouped studies according to intervention type using 4 Fig. 1 . Flow chart of study selection process. categories: educational programs (n ¼ 11 studies), in-reach services (n ¼ 2 studies), medication review (n ¼ 4 studies), and multicomponent interventions (n ¼ 5 studies). The EPOC Data Collection Checklist includes a taxonomy of intervention components grouped under 4 headings: professional, organizational, structural, and regulatory. 16 The interventions within studies of educational programs 14,18e20,23e25,29e32 consisted mainly of professional components, such as educational meetings, distribution of educational materials, and educational outreach. In-reach services 21, 26 contained mainly organizational and structural components. Studies containing the most variety were those in the medication review 22,33e35 and multicomponent intervention groups 27,28,36e39 incorporating educational, organizational, structural, and regulatory interventions. In many cases, there was insufficient information provided in the article to replicate the intervention in another setting. Using the EPOC Data Collection Checklist classification, the number of intervention components per study ranged from 1 to 7; most studies consisted of 3. The most frequently used intervention component was educational outreach (14 studies), and this was evident across all 4 types of intervention. Educational outreach was defined as the use of a trained person who met with providers in their practice settings to give information with the intent of changing the provider's practice.
Study Quality
Assessment of the quality of each included study is shown in Table 4 . The global assessment of just over a third of the studies was moderate or strong. The main areas of weakness were in the collection of primary outcome data and in the reporting of withdrawals and dropouts. In most of the studies, the outcome assessor was aware of the intervention status of participants and the study participants (prescribers) were aware of the research question. Although data on prescribing rates were taken from patient and pharmacy records in many cases, the data-collection process was performed by one individual with no procedure for checking accuracy. Furthermore, the data-collection tool was often not described, precluding judgment on the validity of the measure. In most studies, there was little information provided on the numbers of and reasons for withdrawals and dropouts of either prescribers or patients. In Table 4 we have assessed reporting of withdrawal and dropouts of patients; the reporting of the flow of prescribers was assessed as weak in all but 5 studies. 14, 21, 24, 31, 33 Medication Use Educational programs (randomized and controlled study designs n ¼ 7)
Despite considerable differences in the nature and implementation of the educational programs used, introduction of a program to enhance the management of BPSD behaviors and improve appropriate prescribing of antipsychotic medications had beneficial effects in all 4 randomized studies 14,18e20 and in 1 of the controlled studies. 24 Four of the 5 showed a reduction in medication use in the intervention group compared with the control group of between 12% and 20%. 14, 19, 20, 24 Although Testad and colleagues 18 reported no significant differences between groups in the change in proportion of residents taking antipsychotic medication, this was against a background of reductions in restraint use and agitation (Table 5) . The intervention did not influence prescription rates in the 2 remaining studies. 23, 25 These are the largest studies within the review in terms of the number of patients that the intervention was ultimately aimed at, although the number of physicians receiving training was relatively low, and in the study by Ray and colleagues, 25 training was not offered to nursing and other care home staff. Explanations for the lack of effect offered by the authors of these articles include the simultaneous introduction and promotion of the use of atypical antipsychotics during the study period, 23 a reflection of the wide variation in antipsychotic prescribing in care homes over time, 23 and barriers to reducing antipsychotic prescribing such as the increased time commitment necessary to implement alternative methods of behavior management. 25 Educational programs (before and after study designs n ¼ 4)
The results from these studies are more difficult to interpret, as it is not clear what other factors influenced prescription rates over the study period. Results showed similar trends to those seen in studies of a more robust design. These are smaller single 30e32 or 2-center studies 29 involving between 53 and 300 patients and their associated care staff. The interventions resulted in a decrease in antipsychotic use (variously reported) in 3 studies. 29e31 The baseline level of antipsychotic use in the study reported by Earthy and colleagues 32 was low and little changed by the intervention (increased from 17% to 19%). However, the authors report improvements in documentation, a reduction in administration of "as-needed" medication by nursing staff and a decrease in the frequency of problem behaviors.
In-reach services (randomized and controlled study designs n ¼ 2) Both of these studies involved improved multidisciplinary teamwork either with a psychiatric team 26 or a pharmacist 21 spending time working at care homes supporting the care home staff. In both studies, there were statistically significant reductions in prescription rates associated with the intervention (19%; P ¼.007 21 and 16%; P <.0001 26 ); however, reductions also were seen in the control groups in both studies partly 21 or wholly 26 negating the impact of the intervention.
Medication review (randomized [n ¼ 1] and before and after study designs [n ¼ 3])
The study reported by Patterson and colleagues 22 provides the most robust evidence of the effectiveness of this approach to reducing inappropriate prescribing. The intervention used was also the most sophisticated and used an element of in-reach as well as medication review, with specially trained pharmacists visiting intervention homes monthly for 12 months to review prescribing information and guide prescribing decisions. The authors reported a significant difference between intervention and control homes in the proportion of residents taking inappropriate antipsychotic medications (20% vs 50% [odds ratio ¼ 0.26; 95% confidence interval 0.14e0.49]). The design of the remaining 3 studies permits the consideration of trends in results only. Two used audit and feedback and reminders to review medication needs on a regular basis 33, 34 and these resulted in minimal changes in prescribing rates. The final study was conducted against a background of changes in accommodation conditions for the residents such that they were moved into a specialized, secure dementia unit. Perhaps unsurprisingly, prescription rates were reduced from the extremely high (95% of residents receiving antipsychotic medication) to a much lower proportion (58%), although it is not possible to determine whether this was due to the change in accommodation or the intervention. Reduction in medication use during the intervention. Difference compared to baseline (P < .0001).
13.5% at 12/12
The reduction in medication use was maintained at 9 months after the end of the intervention period. The 5 studies using multicomponent interventions ranged in complexity from a study involving 3 components, audit and feedback, continuity of care, and change to the site of service delivery 36 to 7 components incorporating education, audit and feedback, and structural changes. 27, 28 Studies also varied widely in size, and were implemented in between 1 and 25 homes. All studies showed reductions in prescription rates (ranging from 5% to 66%) associated with the intervention, although only the study reported by Westbury and colleagues was controlled.
27,28
Long-term effects of interventions Only 4 studies assessed whether changes to prescription levels achieved during the intervention period were maintained. Two studies reported a return to baseline antipsychotic prescription levels. 27e29 Testad and colleagues 18 reported that medication levels remained constant 6 months after the end of the intervention. Finally, Rovner and colleagues 39 reassessed psychotropic drug use 9 months after the end of the study period and found the effects in the intervention on prescription rates had been maintained. Detail is sparse because these follow-up visits were outside of the formal trial period, but it is likely that the extent to which procedures used during the study continued to be used varied between sites both within the same trial and between trials. For example, Monette and colleagues 29 commented that although staff at the long-term care centers had expressed an intention to adopt some of the program components, none were systematically adopted after the study. In contrast, Rovner and colleagues 39 attribute the maintenance of the effect of the intervention in their study to an ongoing requirement for physicians to complete an "indications and side effects" document for each resident receiving psychoactive medication.
39

Discussion
Principal Findings
This is the first systematic review to specifically synthesize evidence of the effectiveness of interventions to reduce inappropriate prescribing of antipsychotics to people with dementia resident in care homes. Irrespective of the nature of the intervention, in the studies with the most robust design, antipsychotic prescription rates were seen to fall as a result of the intervention. Although, more difficult to interpret, similar effects were also seen in the less well-designed studies. There is little information in the included studies to aid understanding of the sustainability of the effects of interventions. Furthermore, one of the striking features of this body of literature is that it spans 27 years, with the earliest trial reported in 1987. Over this period, there have been a variety of initiatives, including changes in regulations and widely disseminated guidance aimed at limiting the use of these agents, but evidently prescribers still find compelling reasons to use them.
Results in Context
This work highlights 2 key issues that have been illustrated in previous systematic reviews of related areas: (1) the challenges of changing practice within care homes and (2) the scarcity of goodquality research conducted in this setting. This body of literature spans an extended time period during which research and reporting methods have improved considerably; however, 6 of the included before and after studies were conducted within the last 4 years. We specifically searched for qualitative information on the views and experiences of prescribers using the included interventions, but disappointingly were unable to locate any articles meeting our inclusion criteria. Studies exploring factors that influence prescribing behavior more generally suggest a variety of factors may be involved. These include shortfalls in time, staffing levels, and staff training that impact on nonpharmacological alternatives to antipsychotic medication being considered viable, a pressure from family members and carers to prescribe and a misconception of the likelihood that an individual might benefit from antipsychotic medication. 40e44 Other studies that have looked at implementation of interventions for other purposes in care home settings have identified the importance of involving family members in decision-making in the successful management of behavioral problems 45 and the management of incontinence. 46 A systematic review of the implementation of psychosocial interventions for people with dementia in care homes found that active engagement of care-home staff and family members played a crucial role in successful implementation. 47 Similarly, systematic reviews on the more general topic of improving prescribing practice in care homes 48e53 also have been unable to make clear recommendations for future practice due to the varied nature of the design, interventions, outcomes, and results 49, 50, 53 and the poor quality of included studies.
48,51,52
Strengths and Limitations of Our Study
This systematic review followed best practice guidelines for systematic reviews, 15 is reported according to the PRISMA statement, 54 and is the first in this topic area. Extensive electronic searches that were not limited by date, study design, or language were augmented with forward and backward citation searching of all included articles, and authors of conference abstracts were contacted for their data, where possible. We are, therefore, confident that this review encompasses most if not all the available data on this topic. We focused the review on one outcome measure, change in medication use, but were unable to perform a meta-analysis of the randomized clinical trials because of the variety of formats in which these data was presented. This is undoubtedly a limitation of the review but given the uniformity of the direction of the effect in most of the studies, the small number of randomized clinical trials identified, and the accompanying variation and complexity in the interventions used, it is unlikely that a pooled result would provide any more useful insight than the synthesis we present. Although the results of the before and after studies are difficult to interpret, as there may have been other influences on prescribing during the study period, they provide a full picture of the spectrum of interventions that have been evaluated and add weight to the evidence, as interventions implemented in less tightly controlled conditions also may have produced positive results. We had hoped to explore in more depth whether specific attributes or implementation approaches impacted on the effectiveness of interventions. Because of the relatively small number of robust studies within each category and the lack of reported detail, this was not possible, although we have used a recognized method of characterizing the components of interventions 16 to provide the reader with as much detail as possible.
Implications for Practice and Research
The overall picture is one in which it would seem that the current guidelines to limit antipsychotic prescribing are difficult to implement in the day-to-day reality of practice, whilst juggling ethical concerns, staffing levels, staff competence with nonpharmacological alternatives, and the wishes of distressed relatives and carers. Large, good quality, well-reported, randomized research within the care home setting with accompanying process evaluations would enable a better understanding of the environment and its impact on successful implementation of interventions. Further qualitative work to explore the barriers and facilitators to the appropriate prescription of antipsychotic medications will support efforts to achieve sustained change in the varying specific contexts of individual care and nursing homes.
Conclusions
Interventions to reduce inappropriate prescribing of antipsychotic medications to people with dementia resident in care homes may be effective in the short term, but longer-term, more robust studies are needed. For prescribing levels to be reduced in the long term, the culture and nature of care settings and the availability and feasibility of nondrug alternatives needs to be addressed.
